Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00p -3.36% 57.50p 57.00p 58.00p 59.50p 57.50p 59.50p 33,447.00 12:57:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 0.4 -5.4 -8.6 - 43.02

Angle (AGL) Latest News

Angle News

Date Time Source Headline
24/11/201614:48UKREGAngle PLC Result of GM
04/11/201609:23ALNCAngle Welcomes Supportive Research On Using Parsortix System
04/11/201607:27ALNCFAlliance News Flash Headline
04/11/201607:00UKREGAngle PLC Barts Research Supports Potential Use of Parsortix
01/11/201607:00UKREGAngle PLC Notice of GM
27/10/201606:01UKREGAngle PLC Director's share purchase
07/10/201610:57UKREGAngle PLC Holding(s) in Company
04/10/201615:35UKREGAngle PLC Result of AGM
30/9/201606:00UKREGAngle PLC Research published in Clinical Chemistry
More Angle News
Angle Takeover Rumours

Angle (AGL) Share Charts

1 Year Angle Chart

1 Year Angle Chart

1 Month Angle Chart

1 Month Angle Chart

Intraday Angle Chart

Intraday Angle Chart

Angle (AGL) Discussions and Chat

Angle Forums and Chat

Date Time Title Posts
09/12/201613:38ANGLE 2016 – LIQUID BIOPSY TAKEOVER TARGET4,545.00
08/10/201611:43Angle PLC 201130,115.00
02/12/201513:04Angle 2016 – Liquid Biopsy Takeover Target-
23/9/201410:32Angle (35p) Broker value 126p (26/2/10)3,885.00

Add a New Thread

Angle (AGL) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Angle trades in real-time

Angle (AGL) Top Chat Posts

Angle Daily Update: Angle Plc is listed in the Support Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 59.50p.
Angle Plc has a 4 week average price of 60.59p and a 12 week average price of 64.60p.
The 1 year high share price is 81.50p while the 1 year low share price is currently 53p.
There are currently 74,815,774 shares in issue and the average daily traded volume is 40,364 shares. The market capitalisation of Angle Plc is £43,767,227.79.
banshee: From a liquid biopsy article about 12 months ago "Vermillion (NASDAQ:VRML) Founded in 1993, Austin based Vermillion has lost -78% of their share price value in the past 5 years giving the Company a market cap of just $86 million. Vermillion has developed the first FDA-cleared, multi-biomarker blood test that helps assess the risk of ovarian cancer prior to surgery. The Company brought in minuscule revenues in Q3 2015 making investors wonder just when this product offering will take off." Vermillion are the makers of the $600 OVA1 (now in v2 OVERA form ) test that has been mentioned a few times, not least by AGL as a target price point comparison. Their cap has drifted down since the above was written is now the same as AGL's but hopefully AGL can do better. Vermillion did 2200 odd tests in q3 2016 (100% up on previous year thanks to OVERA replacing OVA1, and are on course to lose $12 million plus this year similar to AGL). Since OVERA is pretty much all they have bar some minor lab work they make AGL look cheap. :) and were once valued at $350 million just on an Ovarian test -now of course their test is on the mkt and FDA approved, but its peformance seems underwhelming. Http:// Http:// Http://
life guard: Correct me if I am wrong but isn't part of the problem with comparing the share price to a year or 2 years ago is the number of dilutions that have occurred to raise money. The market cap is circa 45 million and from memory that was what is before dilution with a higher share price. Another BIO I am in borrowed funds rather than dilution and the share price shot up.. Going forward due to revenue I hope AN looks to borrow as an option and stop future dilution on jam tomorrow promises.
willfy: I don't see the problem with the extra shares, price as to be £1.00 plus to be exercised.Angle is no different to any other PLC company, the staff and directors are in it to make money, like we are, it's not a charitable concern.Once share price is considerably higher, yes the extra shares will be issued, but we will all be ££in profit as well.And for all you doubters , if AN was not convinced Parsortix was going to make it big, why did AN repurchase his original shares, he could have walked away.And by issuing the extra shares once share price as risen, we all make money as well.Finally, this was agreed and voted on at the AGM, democracy rulesFinally
gary38: Every time the share price starts to move AGL management comes with something to put more money in their pockets and the share price goes down.AGL managment you have had plenty now it's time to give some to the shareholders and Stop being so greedy.
gary38: Angle PLC ISSUE OF SHARE OPTIONSSource: UK Regulatory (RNS & others)TIDMAGLRNS Number : 2366QAngle PLC28 November 2016 For immediate release 28 November 2016 ANGLE plc("ANGLE" or the "Company")ISSUE OF SHARE OPTIONSANGLE plc (AIM: AGL; OTCQX: ANPCY), the specialist medtech company, announces that under the shareholder approved Remuneration Policy the Remuneration Committee has approved the issue of 1,500,000 share options to the Company's executive directors. The Remuneration Committee has also approved the issue of 1,805,000 share options to certain staff.Following the issue of these share options, the Company will have outstanding options over a total of 10,365,806 ordinary shares of GBP0.10, representing approximately 11.6% of its issued and to be issued share capital. This leaves approximately 3.9 million options unallocated within the approved limit of up to 16% of the issued and to be issued share capital from time to time.The exercise price for the new share options is 64.50 pence per share, representing the Company's closing mid-market share price on 25 November 2016, being the latest practicable date prior to this announcement. The options are subject to service and/or performance conditions.The new share options granted to the executive directors have a term of ten years and are subject to the performance condition that the share price has risen by at least 100% from the share price when the option is issued.Following the issue of the new share options, the total number of share options held by the executive directors of the Company will be:
escapetohome: Willfy i would second that. This share price should be way way higher, but already there is a huge mrkt cap at this share price. How can it be justified triple the value ? The market cap is justified on sales turnover and that is piffling. I hope you are right --- nobody nobody likes this share price if you are a holder. Miavoce, thanks for the clarification.
escapetohome: Perhaps how netsci performs tomorrow on the fda news and the other news CE MARK will give somewhat of a tiny flavour of what agl share price will do on fda news. I know netsci not full fda , thts why i said small flavour !
willfy: It's a huge market, worth up to 20 billion dollars in a few yrs, and angle would only need a very small percentage to reach a four figure share price.I would be more worried if there weren't any competitors out there, proves there is a market for liquid biopsy.As for the share price, hugely frustrating as it is, I firmly believe once Angle as the successful clinical trial results for ovarian cancer, the share price will react accordingly.
banshee: Indeed, I think AN now expects the AGL Share Price to undergo the financial equivalent of a multiple orgasm in the next few months, if that presentation was anything to go by. He might as well have been holding a sign up saying "This is going to multibag" during his talk.
willfy: Maybe because there is finally a trade on there, 100 buy AGL share price as slumped, but the American share price as not moved, so probably in line with our share price
Angle share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20161209 13:39:53